KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Asset Utilization Ratio (2010 - 2026)

Edwards Lifesciences' quarterly Asset Utilization Ratio came in at 0.47 in Q1 2026, up 10.17% year-on-year from 0.42 in Q1 2025, and up 3.7% quarter-over-quarter from 0.45 in Q4 2025.

Edwards Lifesciences has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.47 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 10.17% year-over-year to 0.47; the trailing twelve-month figure through Mar 2026 stood at 0.47 (up 10.17% YoY), and the FY2025 full-year result was 0.45, down 6.52% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.47, up from 0.45 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.64 in Q2 2022, with the low at 0.42 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 0.5, with a median of 0.48 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio slipped 27.74% in 2023 and climbed 10.17% in 2026.
  • Tracing EW's Asset Utilization Ratio over 5 years: stood at 0.53 in 2022, then grew by 1.43% to 0.53 in 2023, then slipped by 21.85% to 0.42 in 2024, then climbed by 7.65% to 0.45 in 2025, then advanced by 3.7% to 0.47 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.47 (Q1 2026), 0.45 (Q4 2025), and 0.44 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 0.37

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.47
Dec 31, 2025 0.45
Sep 30, 2025 0.44
Jun 30, 2025 0.43
Mar 31, 2025 0.42
Dec 31, 2024 0.42
Sep 30, 2024 0.46
Jun 30, 2024 0.53
Mar 31, 2024 0.54
Dec 31, 2023 0.53
Sep 30, 2023 0.45
Jun 30, 2023 0.48
Mar 31, 2023 0.51
Dec 31, 2022 0.53
Sep 30, 2022 0.63
Jun 30, 2022 0.64
Mar 31, 2022 0.63
Dec 31, 2021 0.63
Sep 30, 2021 0.64
Jun 30, 2021 0.66
Mar 31, 2021 0.62
Dec 31, 2020 0.62
Sep 30, 2020 0.66
Jun 30, 2020 0.69
Mar 31, 2020 0.71
Dec 31, 2019 0.70
Sep 30, 2019 0.72
Jun 30, 2019 0.72
Mar 31, 2019 0.71
Dec 31, 2018 0.66
Sep 30, 2018 0.62
Jun 30, 2018 0.62
Mar 31, 2018 0.60
Dec 31, 2017 0.62
Sep 30, 2017 0.62
Jun 30, 2017 0.65
Mar 31, 2017 0.68
Dec 31, 2016 0.67
Sep 30, 2016 0.68
Jun 30, 2016 0.69
Mar 31, 2016 0.66
Dec 31, 2015 0.63
Sep 30, 2015 0.65
Jun 30, 2015 0.69
Mar 31, 2015 0.68
Dec 31, 2014 0.68
Sep 30, 2014 0.67
Jun 30, 2014 0.71
Mar 31, 2014 0.77
Dec 31, 2013 0.78
Sep 30, 2013 0.83
Jun 30, 2013 0.85
Mar 31, 2013 0.86
Dec 31, 2012 0.86
Sep 30, 2012 0.85
Jun 30, 2012 0.87
Mar 31, 2012 0.87
Dec 31, 2011 0.85
Sep 30, 2011 0.82
Jun 30, 2011 0.80
Mar 31, 2011 0.82
Dec 31, 2010 0.83
Sep 30, 2010 0.83